Harbin Medisan Pharmaceutical Co., Ltd.

Founded in 1996 and listed in Shenzhen Stock Exchange (referred to as Hasanlian, stock code: 002900) since September 22, 2017.Harbin Sanlian mainly engages in the research and development, production and sales of products related to the fields of medicine, animal health care and big health. Among them, the pharmaceutical sector, as the company's main business, mainly covers chemical preparations and active pharmaceutical ingredients. It involves multiple fields such as the nervous system, cardiovascular system, musculoskeletal system, systemic anti-infective drugs, basic infusion and nutritional infusion, anti-tumor drugs and immunomodulators, digestive tract and metabolism.